What are the factors associated with long‐term glycaemic control in patients with type 2 diabetes and elevated glycated haemoglobin (≥7.0%) at initiation of second‐line therapy? Results from the DISCOVER study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

What are the factors associated with long‐term glycaemic control in patients with type 2 diabetes and elevated glycated haemoglobin (≥7.0%) at initiation of second‐line therapy? Results from the DISCOVER study

Published:2021-08-02 Issue:10 Volume:23 Page:2336-2343
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obes Metab

Author:

Bonnet Fabrice¹^ORCID,Chen Hungta²,Cooper Andrew³,Gomes Marίlia B.⁴^ORCID,Ji Linong⁵^ORCID,Leigh Paul³,Ramirez Larisa⁶,Shestakova Marina V.⁷,Shimomura Iichiro⁸,Siddiqui Afrah³,Tang Fengming⁹,Vora Jiten¹⁰,Watada Hirotaka¹¹^ORCID,Khunti Kamlesh¹²^ORCID

Affiliation:

1. Department of Endocrinology Rennes University Hospital, Rennes 1 University Rennes France

2. AstraZeneca Gaithersburg Maryland USA

3. AstraZeneca Cambridge UK

4. Rio de Janeiro State University Rio de Janeiro Brazil

5. Peking University People's Hospital Beijing China

6. AstraZeneca Luton UK

7. Endocrinology Research Center, Diabetes Institute Moscow Russian Federation

8. Graduate School of Medicine Osaka University Osaka Japan

9. Saint Luke's Mid America Heart Institute Kansas City Missouri USA

10. University of Liverpool Liverpool UK

11. Graduate School of Medicine Juntendo University Tokyo Japan

12. University of Leicester Leicester UK

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dom.14476

Reference22 articles.

1. Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

2. Consensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Comprehensive Type 2 Diabetes Management Algorithm – 2019 Executive Summary

3. Microvascular and Macrovascular Complications of Diabetes

4. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies

5. Type 2 diabetes and quality of life

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association between mean platelet volume and the risk of type 2 diabetes mellitus among women with history of gestational diabetes mellitus;BMC Endocrine Disorders;2024-08-27

2. Crosstalk between glucagon-like peptide 1 and gut microbiota in metabolic diseases;mBio;2024-01-16

3. Glucose‐lowering drug use in migrants and native Danes with type 2 diabetes: Disparities in combination therapy and drug types;Diabetes, Obesity and Metabolism;2023-08-07

4. The Effectiveness of an eHealth Family-Based Intervention Program in Patients With Uncontrolled Type 2 Diabetes Mellitus (T2DM) in the Community Via WeChat: Randomized Controlled Trial;JMIR mHealth and uHealth;2023-03-20

5. Management of Diabetes and Hypertension within the Gulf Region: Updates on Treatment Practices and Therapies;Diabetes Therapy;2022-06-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3